Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Amortizatization of Intangibles (2016 - 2023)

Historic Amortizatization of Intangibles for Neuroone Medical Technologies (NMTC) over the last 6 years, with Q2 2023 value amounting to $4568.0.

  • Neuroone Medical Technologies' Amortizatization of Intangibles changed N/A to $4568.0 in Q2 2023 from the same period last year, while for Sep 2023 it was $45571.0, marking a year-over-year change of. This contributed to the annual value of $45571.0 for FY2023, which is 29727.14% up from last year.
  • Per Neuroone Medical Technologies' latest filing, its Amortizatization of Intangibles stood at $4568.0 for Q2 2023.
  • Neuroone Medical Technologies' Amortizatization of Intangibles' 5-year high stood at $20765.0 during Q4 2022, with a 5-year trough of $4568.0 in Q2 2023.